External broker reports(aggregated public sources), CCZ Statton Equities

CCZ Statton Equities

CCZ is a leading Australian stockbroking firm providing stockbroking and wealth generation services to private clients and institutional investors. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Equity Bottom-Up

<ul><li>CGS provided a Q3’FY23 trading update with group revenue of $10.9m, +18% vs pcp or $30.5m YTD.</li><li>New clinical trial (CT) contract sales have been weaker than in previous quarters, with $3.4m in signings or $30.7m YTD.</li><li>Mgmt. has flagged a slowdown in decision-making and investment from biotechnology companies as a contributing factor in the weaker contract sales.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

CGS provided a Q3’FY23 trading update with group revenue of $10.9m, +18% vs pcp or $30.5m YTD.New clinical trial (CT) contract sales have been weaker than in previous quarters, with $3.4m in signings or $30.7m YTD.Mgmt. has flagged a slowdown in decision-making and investment from biotechnology companies as a contributing factor in the weaker contract sales.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Cogstate - Eyes on the Prize Despite a Temporary Sales Slowdown

Cogstate Ltd

Cogstate - Eyes on the Prize Despite a Temporary Sales Slowdown